Integra LifeSciences Holdings Operating Margin 2010-2024 | IART
Current and historical operating margin for Integra LifeSciences Holdings (IART) over the last 10 years. The current operating profit margin for Integra LifeSciences Holdings as of September 30, 2024 is 12.32%.
| Integra LifeSciences Holdings Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2024-09-30 | $1.57B | $0.03B | 1.85% |
| 2024-06-30 | $1.57B | $0.06B | 4.09% |
| 2024-03-31 | $1.53B | $0.08B | 5.23% |
| 2023-12-31 | $1.54B | $0.11B | 7.27% |
| 2023-09-30 | $1.54B | $0.14B | 9.34% |
| 2023-06-30 | $1.55B | $0.18B | 11.78% |
| 2023-03-31 | $1.56B | $0.23B | 14.66% |
| 2022-12-31 | $1.56B | $0.24B | 15.34% |
| 2022-09-30 | $1.57B | $0.23B | 14.62% |
| 2022-06-30 | $1.57B | $0.22B | 14.03% |
| 2022-03-31 | $1.56B | $0.21B | 13.59% |
| 2021-12-31 | $1.54B | $0.20B | 12.77% |
| 2021-09-30 | $1.53B | $0.19B | 12.58% |
| 2021-06-30 | $1.51B | $0.19B | 12.86% |
| 2021-03-31 | $1.38B | $0.16B | 11.32% |
| 2020-12-31 | $1.37B | $0.15B | 11.08% |
| 2020-09-30 | $1.38B | $0.14B | 9.80% |
| 2020-06-30 | $1.39B | $0.06B | 4.04% |
| 2020-03-31 | $1.51B | $0.09B | 5.82% |
| 2019-12-31 | $1.52B | $0.09B | 6.13% |
| 2019-09-30 | $1.51B | $0.09B | 6.04% |
| 2019-06-30 | $1.49B | $0.14B | 9.11% |
| 2019-03-31 | $1.48B | $0.12B | 8.00% |
| 2018-12-31 | $1.47B | $0.11B | 7.61% |
| 2018-09-30 | $1.46B | $0.09B | 5.83% |
| 2018-06-30 | $1.37B | $0.07B | 5.25% |
| 2018-03-31 | $1.29B | $0.06B | 4.74% |
| 2017-12-31 | $1.19B | $0.05B | 3.78% |
| 2017-09-30 | $1.08B | $0.08B | 7.34% |
| 2017-06-30 | $1.05B | $0.10B | 9.36% |
| 2017-03-31 | $1.01B | $0.10B | 10.16% |
| 2016-12-31 | $0.99B | $0.12B | 11.59% |
| 2016-09-30 | $0.98B | $0.10B | 10.03% |
| 2016-06-30 | $0.95B | $0.08B | 8.18% |
| 2016-03-31 | $0.92B | $0.08B | 8.72% |
| 2015-12-31 | $0.88B | $0.08B | 8.95% |
| 2015-09-30 | $0.80B | $0.09B | 10.69% |
| 2015-06-30 | $0.77B | $0.09B | 11.99% |
| 2015-03-31 | $0.79B | $0.08B | 10.19% |
| 2014-12-31 | $0.80B | $0.07B | 8.53% |
| 2014-09-30 | $0.73B | $0.10B | 13.93% |
| 2014-06-30 | $0.74B | $0.05B | 7.16% |
| 2014-03-31 | $0.72B | $0.05B | 6.57% |
| 2013-12-31 | $0.70B | $0.04B | 5.16% |
| 2013-09-30 | $0.83B | $-0.01B | -0.96% |
| 2013-06-30 | $0.83B | $0.04B | 5.20% |
| 2013-03-31 | $0.83B | $0.06B | 6.62% |
| 2012-12-31 | $0.83B | $0.07B | 8.92% |
| 2012-09-30 | $0.82B | $0.06B | 7.68% |
| 2012-06-30 | $0.81B | $0.06B | 7.51% |
| 2012-03-31 | $0.80B | $0.05B | 6.42% |
| 2011-12-31 | $0.78B | $0.06B | 7.05% |
| 2011-09-30 | $0.77B | $0.07B | 9.22% |
| 2011-06-30 | $0.76B | $0.08B | 10.60% |
| 2011-03-31 | $0.74B | $0.10B | 13.09% |
| 2010-12-31 | $0.73B | $0.10B | 13.51% |
| 2010-09-30 | $0.72B | $0.10B | 14.25% |
| 2010-06-30 | $0.71B | $0.10B | 14.12% |
| 2010-03-31 | $0.70B | $0.10B | 14.24% |
| 2009-12-31 | $0.68B | $0.10B | 14.35% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $2.016B | $1.542B |
| Integra LifeSciences is one of the world leaders in regenerative medicine. The company develops, manufactures and markets cost-effective surgical implants and medical instruments. The company now manufactures and sells products in the following two global reportable business segments: Codman Specialty Surgical (CSS) and Orthopedics and Tissue Technologies (OTT). The CSS business offers global, market-leading technologies, brands and instrumentation. The global commercial network includes clinical specialists, a large direct global sales force and strategic partnerships and distributors that serve hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers and health care providers in North America, South America, Europe, Asia Pacific, Middle East and Africa. The Tissue Technologies segment includes wound reconstruction and repair products, bone grafts and nerve and tendon repair products. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $217.348B | 26.52 |
| Intuitive Surgical (ISRG) | United States | $203.988B | 93.58 |
| Alcon (ALC) | Switzerland | $45.073B | 30.16 |
| Edwards Lifesciences (EW) | United States | $41.952B | 26.64 |
| IQVIA Holdings (IQV) | United States | $35.950B | 19.81 |
| IDEXX Laboratories (IDXX) | United States | $34.289B | 40.38 |
| DexCom (DXCM) | United States | $33.759B | 50.84 |
| Waters (WAT) | United States | $23.998B | 35.49 |
| STERIS (STE) | Ireland | $21.743B | 25.03 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.798B | 0.00 |
| Hologic (HOLX) | United States | $16.119B | 17.50 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $14.577B | 14.96 |
| Globus Medical (GMED) | United States | $12.635B | 32.00 |
| Sysmex ADR (SSMXY) | Japan | $12.243B | 38.39 |
| Penumbra (PEN) | United States | $10.352B | 101.40 |
| Masimo (MASI) | United States | $9.509B | 46.01 |
| Glaukos (GKOS) | United States | $8.767B | 0.00 |
| Teleflex (TFX) | United States | $8.387B | 13.38 |
| Integer Holdings (ITGR) | United States | $4.804B | 27.23 |
| Inari Medical (NARI) | United States | $4.666B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $3.807B | 0.00 |
| Veracyte (VCYT) | United States | $3.444B | 103.35 |
| LivaNova (LIVN) | United Kingdom | $2.755B | 15.90 |
| Nihon Kohden (NHNKY) | Japan | $2.554B | 19.40 |
| Tandem Diabetes Care (TNDM) | United States | $2.388B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.309B | 20.76 |
| TransMedics (TMDX) | United States | $2.199B | 69.71 |
| Alphatec Holdings (ATEC) | United States | $1.710B | 0.00 |
| Artivion (AORT) | United States | $1.309B | 86.72 |
| RxSight (RXST) | United States | $1.273B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.214B | 0.00 |
| Paragon 28 (FNA) | United States | $1.088B | 0.00 |
| OPKO Health (OPK) | United States | $1.024B | 0.00 |
| AxoGen (AXGN) | United States | $0.806B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.795B | 13.51 |
| IRadimed (IRMD) | United States | $0.759B | 40.99 |
| Mesa Laboratories (MLAB) | United States | $0.743B | 17.51 |
| SiBone (SIBN) | United States | $0.722B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.715B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.649B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.602B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.504B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.500B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.491B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.483B | 25.41 |
| NeuroPace (NPCE) | United States | $0.438B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.429B | 23.23 |
| Pacific Biosciences Of California (PACB) | United States | $0.427B | 0.00 |
| CVRx (CVRX) | United States | $0.409B | 0.00 |
| Inogen (INGN) | United States | $0.298B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.255B | 0.00 |
| Accuray (ARAY) | United States | $0.223B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.214B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.197B | 0.00 |
| Nevro (NVRO) | United States | $0.190B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.155B | 0.00 |
| LENSAR (LNSR) | United States | $0.129B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.110B | 11.75 |
| Atossa Genetics (ATOS) | United States | $0.107B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.105B | 0.00 |
| Neuronetics (STIM) | United States | $0.097B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.096B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.085B | 0.00 |
| 908 Devices (MASS) | United States | $0.082B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.076B | 0.00 |
| Hyperfine (HYPR) | United States | $0.072B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.069B | 0.00 |
| InspireMD (NSPR) | Israel | $0.063B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.059B | 30.86 |
| EnVVeno Medical (NVNO) | United States | $0.055B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.053B | 0.00 |
| Positron (POSC) | United States | $0.051B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.046B | 0.00 | |
| Microbot Medical (MBOT) | United States | $0.036B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.036B | 0.00 |
| Spectral AI (MDAI) | United States | $0.034B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| NexGel (NXGL) | United States | $0.024B | 0.00 |
| DarioHealth (DRIO) | United States | $0.022B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.016B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.015B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.007B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.006B | 0.00 |
| Tenon Medical (TNON) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.005B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |